Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months

TL Diepgen; - ETAC Study Group; Arnold Oranje

Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months

TL Diepgen, - ETAC Study Group, Arnold Oranje

Dermatology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	278-286
Number of pages	9
Journal	Pediatric Allergy and Immunology
Volume	13
Publication status	Published - 2002

Research programs

EMC MM-03-61-05-A

Cite this

@article{327df463d0674131937717079e1e4180,

title = "Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months",

author = "TL Diepgen and \{ETAC Study Group\}, - and Arnold Oranje",

year = "2002",

language = "Undefined/Unknown",

volume = "13",

pages = "278--286",

journal = "Pediatric Allergy and Immunology",

issn = "0905-6157",

publisher = "Blackwell Publishing",

}

Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months. / Diepgen, TL; ETAC Study Group, -; Oranje, Arnold.
In: Pediatric Allergy and Immunology, Vol. 13, 2002, p. 278-286.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Long-term treatment with centrilizine of infants with atopic dermatitis: a multi-country, double-blind, randomized, placebo-controlled trial (The ETAC trial) over 18 months

AU - Diepgen, TL

AU - ETAC Study Group, -

AU - Oranje, Arnold

PY - 2002

Y1 - 2002

M3 - Article

SN - 0905-6157

VL - 13

SP - 278

EP - 286

JO - Pediatric Allergy and Immunology

JF - Pediatric Allergy and Immunology

ER -